Skip to content
Tenfell
Closed tender
Published 03 Jun 2020

Framework Agreement For Producer Cell Line For GMP Viral Vector Packaging

NHS Blood and Transplant · United Kingdom

Key facts

Estimated value
£100,000
Closing date
05 Jul 2020
Contract starts
30 Apr 2021
Contract ends
30 Sep 2023
Procedure
Open procedure (above threshold)
Buyer type
Health

Description

NHSBT's Clinical Biotechnology Centre has a requirement for specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.